|
Cancer and Leukemia Group B
|
5U10CA031946-26
|
$10,080,981
|
$705,669
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-28
|
$5,064,881
|
$354,542
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
Chronic Lymphocytic Leukemia Research Consortium
|
5P01CA081534-08
|
$3,827,483
|
$765,497
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
THERAPY OF CML
|
5P01CA049639-19
|
$3,552,240
|
$355,224
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Hematopoietic Cell Transplantation for Hematologic Malignancies
|
5P01CA030206-25
|
$2,776,839
|
$555,368
|
FORMAN, STEPHEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
SPORE in Genitourinary Cancer
|
5P50CA091846-07
|
$2,549,962
|
$509,992
|
DINNEY, COLIN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE IN PROSTATE CANCER
|
5P50CA058236-13
|
$2,532,522
|
$506,504
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Radiologial Physics Center
|
5U10CA010953-39
|
$2,431,121
|
$24,311
|
IBBOTT, GEOFFREY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE in Lung Cancer
|
5P50CA070907-10
|
$2,353,640
|
$470,728
|
MINNA, JOHN
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
SPORE in Prostate Cancer
|
5P50CA091956-07
|
$2,277,704
|
$455,541
|
TINDALL, DONALD
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-08
|
$2,249,522
|
$449,904
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Biology & Transplantation of the Human Stem Cell
|
5P01CA065493-13
|
$2,065,942
|
$1,032,971
|
MCGLAVE, PHILIP
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Genetic Approaches to Cancer Immunotherapy
|
5P01CA059350-14
|
$1,984,035
|
$1,091,219
|
SADELAIN, MICHEL
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
The UCLA Center for In Vivo Imaging in Cancer Biology
|
5P50CA086306-08
|
$1,891,032
|
$472,758
|
HERSCHMAN, HARVEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Quality Assurance Review Center
|
2U10CA029511-28
|
$1,871,106
|
$18,711
|
FITZGERALD, THOMAS
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
Pediatric Oncology Branch Clinical Care and Education
|
Z01 BC 010764
|
$1,869,714
|
$18,697
|
Wayne, Alan
|
CCR (NCI)
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-21
|
$1,860,642
|
$18,606
|
ATKINS, JAMES
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Immunotherapy with High Frequency, CEA Specific T Cells
|
5P01CA078673-08
|
$1,766,526
|
$1,766,526
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Clinical and Laboratory Studies of Malignant Lymphomas
|
5P01CA034233-23
|
$1,662,201
|
$332,440
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA037447-24
|
$1,615,920
|
$64,637
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Gene Therapy for Brain Tumors
|
5P01CA069246-11
|
$1,357,853
|
$475,249
|
HOCHBERG, FRED
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Molecular Gene and Radiation Therapies for Cancer
|
5P01CA097012-04
|
$1,347,203
|
$336,801
|
FREYTAG, SVEND
|
HENRY FORD HEALTH SYSTEM
|
|
Immuno/Immunogene Therapies for Thoracic Malignancies
|
5P01CA066726-11
|
$1,181,405
|
$590,703
|
Albelda, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
MD Anderson Cancer Center SPORE in Head and Neck Cancer
|
3P50CA097007-05S1
|
$1,150,000
|
$230,000
|
LIPPMAN, SCOTT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
SPORE in Prostate Cancer
|
3P50CA058204-13S1
|
$1,124,001
|
$112,400
|
ITTMANN, MICHAEL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Molecular Therapeutics for Anaplastic Gliomas
|
3P50CA097247-05S2
|
$1,073,000
|
$429,200
|
GILLESPIE, G.
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Cancer and Leukemia Group B-Leukemia Correlative Science
|
5U10CA101140-05
|
$994,868
|
$69,641
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM
|
5U10CA035178-24
|
$936,039
|
$9,360
|
Lange, Marianne
|
SPECTRUM HEALTH HOSPITALS
|
|
Delaware/Christiana Care CCOP
|
2U10CA045418-21
|
$835,003
|
$8,350
|
GRUBBS, STEPHEN
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
MOUNT SINAI COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA045564-21
|
$813,998
|
$8,140
|
Lilenbaum, Rogerio
|
MOUNT SINAI MEDICAL CENTER (MIAMI BEACH)
|
|
Clinical study of AdV-tk radiogenetherapy for malignant*
|
4R44CA107745-03
|
$788,188
|
$394,094
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Greenville SC CCOP
|
2U10CA067663-12
|
$740,000
|
$7,400
|
GIGUERE, JEFFREY
|
ONCOLOGY & HEMATOLOGY ASSOCIATES OF SC
|
|
Minority Based Community Clinical Oncology Program
|
2U10CA074811-10
|
$705,000
|
$7,050
|
PEACE, DAVID
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Heartland Research Consortium CCOP
|
5U10CA114558-03
|
$704,999
|
$7,050
|
LYSS, ALAN
|
MISSOURI BAPTIST MEDICAL CENTER
|
|
Phase I Trials of Anti-Cancer Agents
|
5U01CA076576-10
|
$701,378
|
$28,055
|
GREVER, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Targeting the Tumor Vasculature to Treat Cancer
|
Z01 SC 010368
|
$689,963
|
$68,996
|
Libutti, Steven
|
CCR (NCI)
|
|
Northern Indiana Cancer Research Consortium CCOP
|
5U10CA086726-08
|
$688,878
|
$6,889
|
Zon, Robin
|
MEMORIAL HOSPITAL OF SOUTH BEND
|
|
Kansas City Clinical Oncology Program CCOP
|
5U10CA035176-24
|
$672,441
|
$6,724
|
Gaur, Rakesh
|
KANSAS CITY CLINICAL ONCOLOGY PROGRAM
|
|
Nevada Cancer Research Foundation-Community Clinical Oncology Program
|
2U10CA035421-24
|
$650,000
|
$6,500
|
ELLERTON, JOHN
|
SOUTHERN NEVADA CANCER RESEARCH FDN
|
|
Anti-Idiotype Therapy of Human B Cell Malignancy
|
5R37CA033399-26
|
$594,988
|
$297,494
|
LEVY, RONALD
|
STANFORD UNIVERSITY
|
|
Illinois Oncology Research Association CCOP
|
5U10CA035113-24
|
$578,969
|
$5,790
|
KUGLER, JOHN
|
ONCOLOGY-HEMATOLOGY ASSOC-CENTRAL ILL
|
|
Early Clinical Trials of New Anti Cancer Agents
|
5U01CA062491-14
|
$558,617
|
$16,759
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Syracuse Hematology-Oncology CCOP
|
5U10CA045389-21
|
$536,473
|
$5,365
|
KIRSHNER, JEFFREY
|
HEMATOLOGY-ONCOLOGY ASSOCIATES/CTL NY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-17
|
$527,332
|
$5,273
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Radiation, Hormones & Antisense Prostate Cancer Therapy
|
5R01CA101984-05
|
$506,334
|
$253,167
|
POLLACK, ALAN
|
FOX CHASE CANCER CENTER
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$4,800
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
Cancer and Leukemia Group B
|
3U10CA031946-26S2
|
$450,000
|
$31,500
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-10
|
$434,962
|
$30,447
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
EORTC DATA CENTER
|
5U10CA011488-37
|
$417,479
|
$4,175
|
Sylvester, Richard
|
EUROPEAN ORG/RES/TREATMENT/CANCER
|
|
Community Clinical Oncology Program
|
5U10CA035199-24
|
$413,073
|
$4,131
|
Grinblatt, David
|
EVANSTON NORTHWESTERN HEALTHCARE
|
Total relevant funding to Gene Therapy Clinical Trials for this search: $16,341,118
|